These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12826800)

  • 1. Proton pump inhibitors control osteoclastic resorption of calcium phosphate implants and stimulate increased local reparative bone growth.
    Rzeszutek K; Sarraf F; Davies JE
    J Craniofac Surg; 2003 May; 14(3):301-7. PubMed ID: 12826800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo.
    Sheraly AR; Lickorish D; Sarraf F; Davies JE
    Curr Drug Deliv; 2009 Apr; 6(2):192-8. PubMed ID: 19450226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bafilomycin A1 inhibits bone resorption and tooth eruption in vivo.
    Sundquist KT; Marks SC
    J Bone Miner Res; 1994 Oct; 9(10):1575-82. PubMed ID: 7817803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resorptive state and cell size influence intracellular pH regulation in rabbit osteoclasts cultured on collagen-hydroxyapatite films.
    Lees RL; Sabharwal VK; Heersche JN
    Bone; 2001 Feb; 28(2):187-94. PubMed ID: 11182377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strontium substitution in apatitic CaP cements effectively attenuates osteoclastic resorption but does not inhibit osteoclastogenesis.
    Schumacher M; Wagner AS; Kokesch-Himmelreich J; Bernhardt A; Rohnke M; Wenisch S; Gelinsky M
    Acta Biomater; 2016 Jun; 37():184-94. PubMed ID: 27084107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of osteoclast vacuolar H(+)-ATPase.
    Farina C; Gagliardi S
    Curr Pharm Des; 2002; 8(23):2033-48. PubMed ID: 12171517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of osteoclast proton transport by bafilomycin A1 abolishes bone resorption.
    Sundquist K; Lakkakorpi P; Wallmark B; Väänänen K
    Biochem Biophys Res Commun; 1990 Apr; 168(1):309-13. PubMed ID: 2139331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]Bafilomycin as a probe for the transmembrane proton channel of the osteoclast vacuolar H(+)-ATPase.
    Mattsson JP; Keeling DJ
    Biochim Biophys Acta; 1996 Apr; 1280(1):98-106. PubMed ID: 8634321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bafilomycin A1 in bone resorption and tooth eruption in dogs.
    Marks SC; Sundquist KT
    Eur J Oral Sci; 1995 Aug; 103(4):231-5. PubMed ID: 7552954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local delivery of iron chelators reduces in vivo remodeling of a calcium phosphate bone graft substitute.
    Drager J; Sheikh Z; Zhang YL; Harvey EJ; Barralet JE
    Acta Biomater; 2016 Sep; 42():411-419. PubMed ID: 27449336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation of pHi in osteoclasts is dependent on the culture substrate and on the stage of the resorption cycle.
    Lehenkari PP; Laitala-Leinonen T; Linna TJ; Väänänen HK
    Biochem Biophys Res Commun; 1997 Jun; 235(3):838-44. PubMed ID: 9207248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacological assessment of the mammalian osteoclast vacuolar H(+)-ATPase.
    Hall TJ; Schaueblin M
    Bone Miner; 1994 Nov; 27(2):159-66. PubMed ID: 7711523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption.
    Karsdal MA; Henriksen K; Sørensen MG; Gram J; Schaller S; Dziegiel MH; Heegaard AM; Christophersen P; Martin TJ; Christiansen C; Bollerslev J
    Am J Pathol; 2005 Feb; 166(2):467-76. PubMed ID: 15681830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory mechanisms of H(+)-ATPase inhibitor bafilomycin A1 and carbonic anhydrase II inhibitor acetazolamide on experimental bone resorption.
    Ohba Y; Ohba T; Sumitani K; Tagami-Kondoh K; Hiura K; Miki Y; Kakegawa H; Takano-Yamamoto T; Katunuma N
    FEBS Lett; 1996 Jun; 387(2-3):175-8. PubMed ID: 8674544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.
    Mattsson JP; Väänänen K; Wallmark B; Lorentzon P
    Biochim Biophys Acta; 1991 Jun; 1065(2):261-8. PubMed ID: 1647821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: a pilot study.
    Taylor JC; Cuff SE; Leger JP; Morra A; Anderson GI
    Int J Oral Maxillofac Implants; 2002; 17(3):321-30. PubMed ID: 12074446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallium enhances reconstructive properties of a calcium phosphate bone biomaterial.
    Strazic Geljic I; Melis N; Boukhechba F; Schaub S; Mellier C; Janvier P; Laugier JP; Bouler JM; Verron E; Scimeca JC
    J Tissue Eng Regen Med; 2018 Feb; 12(2):e854-e866. PubMed ID: 28079305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [V-ATPase inhibitor baflomycine A1 inhibits bone resorption by osteoclast-like cells].
    Zhao N; Yu S
    Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):436-9. PubMed ID: 11869558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphoserine-modified calcium phosphate cements: bioresorption and substitution.
    Offer L; Veigel B; Pavlidis T; Heiss C; Gelinsky M; Reinstorf A; Wenisch S; Lips KS; Schnettler R
    J Tissue Eng Regen Med; 2011 Jan; 5(1):11-9. PubMed ID: 20603870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Na+/H(+)-antiporter activity is essential for the induction, but not the maintenance of osteoclastic bone resorption and cytoplasmic spreading.
    Hall TJ; Schaeublin M; Chambers TJ
    Biochem Biophys Res Commun; 1992 Nov; 188(3):1097-103. PubMed ID: 1332710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.